| Patent Number |
Title Of Patent |
Date Issued |
| 7408044 |
Carrier protein having an adjuvant effect |
August 5, 2008 |
| The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protei |
| 7220545 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical com |
May 22, 2007 |
| A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130 230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a |
| 7125696 |
Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
October 24, 2006 |
| A invention concerns a novel method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent, and polypeptides obtainable by said method. The invention also concerns the use of said polypeptides, in particular for preparing medicines or vaccines, for figh |
| 6780420 |
Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their |
August 24, 2004 |
| The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protei |
| 6616930 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical com |
September 9, 2003 |
| A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a |
| 6537556 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical com |
March 25, 2003 |
| A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a |
| 6410030 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical com |
June 25, 2002 |
| A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a |
| 6197929 |
Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their |
March 6, 2001 |
| The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protei |
| 6113911 |
Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical com |
September 5, 2000 |
| A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a |
